Willis Towers Watson (STU:WTY) Research & Development: €0 Mil (TTM As of Mar. 2026)


STU:WTY Willis Towers Watson PLC STU:WTY
83 GF Score
Price €226.30
GF Value €281.73
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Willis Towers Watson Research & Development?

Willis Towers Watson STU:WTY +2.26% 83 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates STU:WTY with a GF Score™ of 83/100 and a GF Value™ of €281.73 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Willis Towers Watson's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Willis Towers Watson  (STU:WTY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Willis Towers Watson Research & Development Related Terms

Willis Towers Watson Research & Development Historical Data

* Premium members only.

The historical data trend for Willis Towers Watson's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Willis Towers Watson Research & Development Chart

Willis Towers Watson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Willis Towers Watson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:WTY
83GF Score
Willis Towers Watson PLC STU:WTY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Willis Towers Watson Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Willis Towers Watson (STU:WTY) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Willis Towers Watson and its competitors.
Is Willis Towers Watson's Research & Development too high?
Willis Towers Watson's current Research & Development is €0 Mil. Overall, Willis Towers Watson has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Willis Towers Watson's Research & Development compare to BRO and ERIE?
Willis Towers Watson's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Willis Towers Watson and its competitors. Willis Towers Watson's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Willis Towers Watson stock overvalued right now?
Based on GuruFocus' analysis, Willis Towers Watson (STU:WTY) is currently considered Modestly Undervalued. The stock's GF Value™ is €281.73, compared to a current price of €226.30 — trading 19.7% below its estimated fair value. The current Research & Development is €0 Mil. Willis Towers Watson's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Willis Towers Watson (STU:WTY), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Willis Towers Watson (STU:WTY) Overvalued in 2026?

Based on GuruFocus' analysis, Willis Towers Watson stock appears to be undervalued. The current stock price of €226.30 is trading 19.7% below its estimated GF Value™ of €281.73. GuruFocus considers Willis Towers Watson to be Modestly Undervalued.

Key valuation signals for STU:WTY:

  • Research & Development: €0 Mil
  • GF Value™: €281.73 vs. price of €226.30 (19.7% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the STU:WTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Willis Towers Watson Business Description

Address c/o Willis Group Limited, 51 Lime Street, London, GBR, EC3M 7DQ
Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.
83GF Score

Get the complete analysis for STU:WTY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€226.30
Price
€281.73
GF Value